NEW YORK (GenomeWeb News) — Tripos has entered into a material agreement to sell its Discovery Research business to Commonwealth Biotechnologies, according to a term sheet Tripos filed on April 20 with the US Securities and Exchange Commission.
CBI, a molecular diagnostics company based in Richmond, Va., would pay as much as $2.3 million for the unit, broken down into $500,000 in cash and a total of $1.8 million in base receivables. The term sheet expires in early May.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.

Sponsored by

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.